These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14579623)

  • 1. [Subcortical vascular encephalopathy].
    Baezner H; Daffertshofer M
    Ther Umsch; 2003 Sep; 60(9):541-52. PubMed ID: 14579623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current therapy of patients with dementia].
    Fuchsberger T; Möller HJ; Hampel H
    MMW Fortschr Med; 2003 May; 145 Suppl 2():49-52, 54. PubMed ID: 14579485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current strategies of pathogenetic therapy of Alzheimer's disease].
    Gavrilova SI; Zharikov GA
    Vestn Ross Akad Med Nauk; 2001; (7):13-8. PubMed ID: 11523421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment.
    Auriacombe S; Pere JJ;
    Curr Med Res Opin; 2003; 19(8):715-7. PubMed ID: 14687442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
    Alagiakrishnan K; Sclater A; Robertson D
    J Am Geriatr Soc; 2003 Sep; 51(9):1326. PubMed ID: 12919253
    [No Abstract]   [Full Text] [Related]  

  • 7. Amantadine increases gait steadiness in frontal gait disorder due to subcortical vascular encephalopathy: a double-blind randomized placebo-controlled trial based on quantitative gait analysis.
    Baezner H; Oster M; Henning O; Cohen S; Hennerici MG
    Cerebrovasc Dis; 2001; 11(3):235-44. PubMed ID: 11306774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient populations in clinical studies of donepezil in vascular dementia.
    Pratt RD
    Int Psychogeriatr; 2003; 15 Suppl 1():195-200. PubMed ID: 16191240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer's disease. Foreword].
    Derquesné C
    Rev Prat; 1998 Nov; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching from donepezil or rivastigmine to galantamine in clinical practice.
    Edwards K; Therriault O'connor J; Gorman C
    J Am Geriatr Soc; 2004 Nov; 52(11):1965. PubMed ID: 15507085
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of vascular dementias.
    Inzitari D; Lamassa M; Pantoni L; Basile AM
    Arch Gerontol Geriatr Suppl; 2004; (9):229-34. PubMed ID: 15207419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment for Alzheimer's disease.
    Freyne A; Cooney C
    Ir Med J; 1999; 92(7):424-5. PubMed ID: 10967863
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
    Kaufer DI
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial.
    Brassen S; Adler G
    Pharmacopsychiatry; 2003 Nov; 36(6):304-8. PubMed ID: 14663655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer type dementia].
    Ruis J
    Rev Infirm; 2008 Sep; (143):14-5. PubMed ID: 18788658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patchy changes in white matter in cranial computerized and magnetic resonance tomography--significance for (differential) diagnosis of dementia of the Alzheimer type and vascular dementia].
    Stoppe G; Staedt J; Bruhn H
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):425-40. PubMed ID: 8575717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis.
    Thomas DA; Libon DJ; Ledakis GE
    Appl Neuropsychol; 2005; 12(1):12-8. PubMed ID: 15788218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up.
    Moretti R; Torre P; Antonello RM; Cazzato G
    Eur J Neurol; 2001 Jul; 8(4):361-2. PubMed ID: 11422435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.